As of 10 Nov 2026, LionBio has raised $6M across 1 verified round on record; latest: $6 million pre-seed round led by South Park Commons, announced 7 Nov 2026.
LionBio is the nasal peptide company, starting with a nasal GLP-1.
lion.bioUSBiotech
3 sources · checked 2 times, last 1h ago
Source 3 describes South Park Commons as participating, while Source 1 says it led; the latter is used.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed | $6M | 2026-11-07 | South Park Commons | 4 people on X · 3 outlets. #14 in Trending |
3 sources · checked 2 times, last 1h ago [ VERIFIED · CORRECTED ] read against 3 sources
Source 3 describes South Park Commons as participating, while Source 1 says it led; the latter is used. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]3 pages read: en.wowtale.net, oindpnews.com, ecosystem.az·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 3 sources·[ BRANDING ]logo and colour from the homepage·[ ]posts from 4 people, found with Firecrawl search·[ AGENT ]company research by the Firecrawl agent | ||||
4 people on 3 outlets
Found on X with Firecrawl search
LionBio is developing biodegradable nanoparticle nasal delivery for peptide and biologic medicines, starting with semaglutide, a GLP-1 medicine, as a non-injection option for patients.